Law360, New York (March 4, 2013, 11:18 AM EST) -- The 340B drug pricing program was created in 1992. Named after the enacting statutory provision, through the 340B program, pharmaceutical manufacturers provide discounted outpatient prescription drugs to qualifying safety net providers serving uninsured and indigent patients.
The 340B program is administered by the federal Health Resources and Services Administration (HRSA) which, until recently, took a hands-off approach to 340B program oversight. But things are rapidly changing, and 340B entities are under increasing scrutiny.
Multiple factors have converged to impact the 340B program, including:
Expansion of the types of safety net providers who qualify as 340B entities through the Affordable Care Act...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!